orphenadrine has been researched along with Muscular Atrophy in 1 studies
Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Albert, HH | 1 |
1 other study available for orphenadrine and Muscular Atrophy
| Article | Year |
|---|---|
[Therapy in neurology. 10. The cervical syndrome--shoulder-neck-arm pain].
Topics: Cervical Rib Syndrome; Chlormezanone; Diagnosis, Differential; Humans; Muscular Atrophy; Orphenadrin | 1982 |